• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CAMP4 Therapeutics Corporation - Common Stock (NQ:CAMP)

    4.590 +0.510 (+12.50%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 90,940
    Open 3.990
    Bid (Size) 4.200 (100)
    Ask (Size) 5.000 (1,100)
    Prev. Close 4.080
    Today's Range 3.990 - 4.700
    52wk Range 1.305 - 7.305
    Shares Outstanding 20,161,073
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire

    Performance

    YTD
    -23.5%
    -23.5%
    1 Month
    +27.5%
    +27.5%
    3 Month
    +35.4%
    +35.4%
    6 Month
    +210.1%
    +210.1%
    1 Year
    -5.0%
    -5.0%

    More News

    Read More
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗
    Via The Motley Fool
    News headline image
    CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    3 Healthcare Companies Insiders Are Buying ↗
    Via MarketBeat
    Topics Initial Public Offering
    News headline image
    CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Wednesday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    Camp4 Reports Q2 Revenue Beats Estimates ↗
    Via The Motley Fool
    News headline image
    CAMP4 Reports Second Quarter 2025 Financial Results and Corporate Highlights
    From CAMP4 Therapeutics
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Sequans Appoints Jason W. Cohenour to Board of Directors
    Via Newsfile
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    This Sandisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
    Via Benzinga

    Frequently Asked Questions

    Is CAMP4 Therapeutics Corporation - Common Stock publicly traded?
    Yes, CAMP4 Therapeutics Corporation - Common Stock is publicly traded.
    What exchange does CAMP4 Therapeutics Corporation - Common Stock trade on?
    CAMP4 Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for CAMP4 Therapeutics Corporation - Common Stock?
    The ticker symbol for CAMP4 Therapeutics Corporation - Common Stock is CAMP on the Nasdaq Stock Market
    What is the current price of CAMP4 Therapeutics Corporation - Common Stock?
    The current price of CAMP4 Therapeutics Corporation - Common Stock is 4.590
    When was CAMP4 Therapeutics Corporation - Common Stock last traded?
    The last trade of CAMP4 Therapeutics Corporation - Common Stock was at 03/05/26 04:00 PM ET
    What is the market capitalization of CAMP4 Therapeutics Corporation - Common Stock?
    The market capitalization of CAMP4 Therapeutics Corporation - Common Stock is 92.54M
    How many shares of CAMP4 Therapeutics Corporation - Common Stock are outstanding?
    CAMP4 Therapeutics Corporation - Common Stock has 93M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.